Menu

Elena Rybak-Akimova, Chemical Kinetics Expert, Dies

The chemist examined the role of activated oxygen molecules in biological processes.

Mar 16, 2018
Jim Daley

MELODY KO/TUFTS UNIVERSITY

Elena Rybak-Akimova, a chemist at Tufts University who studied how activated oxygen molecules drive biological processes, died of cancer this week (March 11) at age 56.

“She was a fearless scientist,” Krishna Kumar, the Tufts Chemistry Department Chair, says in a statement. “The community recognized her as a ‘chemist’s chemist’—in that she took on problems that were difficult.”

Rybak-Akimova was born in 1961 in Ukraine and earned her PhD in inorganic chemistry from the country’s Academy of Sciences. While in high school, she was the first girl to win a gold medal in Ukraine’s National Chemistry Olympiad, which gave her “legendary status,” Tufts chemist Sergiy Kryatov, who she later coached for the same competition, says in the statement. “She was a wonderful human being. It’s a huge loss.”

In 1992, Rybak-Akimova came to the United States as a postdoctoral researcher at the University of Kansas and joined Tufts in 1997 as an assistant professor. She was committed to advancing the field of chemical kinetics, and in 2010 she co-organized a conference on catalysis science for the US Department of Energy.

Rybak-Akimova spent years investigating small molecules, and her work on how molecular systems activate oxygen molecules led to new insights into how this process works in basic biological processes. “She was always fascinated by how you can take something as benign as oxygen, that through activation can lead to some nasty chemical characters, such as hydroxyl radicals,” Kumar says in the statement.

As an instructor at Tufts, Rybak-Akimova was determined to spark students’ interests in chemistry with spectacular—and often exothermic—demonstrations. On at least one occasion, she accidentally triggered a fire alarm. “The department secretary . . . stepped out of her office to find out what was going on and Elena was jumping around the corridor, saying, ‘I did it! I did it!’” Kryatov says in the statement. “That’s Elena.”

Rybak-Akimova is survived by her husband and two children.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!